Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia
Open Access
- 21 August 2019
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 28 (12) , 3303-3312
Abstract
Purpose Tardive dyskinesia (TD) is a common but serious hyperkinetic movement disorder and side effect of antipsychotic medications used to treat bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SZ). The purpose of this study was to evaluate health-related quality of life (HRQoL) in a population with diagnoses for BD, MDD, or SZ by comparing patients with TD (n = 197) with those without TD (n = 219). HRQoL in each group was also compared with HRQoL of the general population. Methods This study employed a cross-sectional web-based survey. HRQoL was assessed by four instruments: the SF-12 Health Survey, Version 2 (SF-12v2), the Quality of Life Enjoyment and Satisfaction Questionnaire, Short Form (Q-LES-Q-SF), the Social Withdrawal subscale of the Internalized Stigma of Mental Illness Scale (SW-ISMI); and two questions on movement disorders. Results Patients with TD had significantly worse HRQoL and social withdrawal than those without. The differences were more pronounced for physical HRQoL domains than for mental health domains. Patients with more-severe TD, assessed through either self-rating or clinician rating, experienced significantly worse HRQoL than did those with less-severe TD. The impact of TD was substantially greater in patients with SZ than in those with BD or MDD. Compared with the general population, patients with BD, MDD, or SZ experienced significantly worse HRQoL regardless of TD status, although this deficit in HRQoL was greater among those with TD. Conclusions The presence of TD is associated with worse HRQoL and social withdrawal. The most severe impact of TD is on physical aspects of patients’ HRQoL.Keywords
Funding Information
- Teva Pharmaceutical Industries
This publication has 18 references indexed in Scilit:
- Construct Validity of the SF-12v2 for the Homeless Population with Mental Illness: An Instrument to Measure Self-Reported Mental and Physical HealthPLOS ONE, 2016
- Tardive dyskinesia (syndrome): Current concept and modern approaches to its managementPsychiatry and Clinical Neurosciences, 2015
- Tardive dyskinesia syndromes: current conceptsParkinsonism & Related Disorders, 2014
- Tardive dyskinesia from atypical antipsychotic agents in patients with mood disorders in a clinical settingJournal of Affective Disorders, 2013
- Changes in the diagnosed incidence of early onset schizophrenia over four decadesActa Psychiatrica Scandinavica, 2012
- Increasing off‐label use of antipsychotic medications in the United States, 1995–2008Pharmacoepidemiology and Drug Safety, 2011
- Spectrum of tardive syndromes: clinical recognition and managementPostgraduate Medical Journal, 2010
- Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesiaSchizophrenia Research, 2005
- Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesiaActa Psychiatrica Scandinavica, 1996
- Morbidity and mortality in tardive dyskinesia: associations in chronic schizophreniaActa Psychiatrica Scandinavica, 1987